Biomedical engineers are at the forefront of developing novel treatments to improve human
health, however, many products fail to translate to clinical implementation. In vivo pre-clinical …

Background Parkinson's disease (PD) is expected to become more common, particularly
with an aging population. Diagnosis and monitoring of the disease typically rely on the …

The blood-brain barrier (BBB) is composed of a layer of endothelial cells that is interspersed
with a series of tight junctions and characterized by the absence of fenestrations. The …

Advances in high-throughput sequencing over the past decades have led to the
identification of thousands of non-coding RNAs (ncRNAs), which play a major role in …

The objective of this clinical practice guideline is to provide recommendations on the
indications and minimum standards for inpatient long-term video-electroencephalographic …

Around 40% of the population will suffer at some point in their life a disease involving tissue
loss or an inflammatory or autoimmune process that cannot be satisfactorily controlled with …

Ischemic Stroke precedes depression. Post-stroke depression (PSD) is a major driver for
poor recovery, negative quality of life, poor rehabilitation outcomes and poor functional …

Background Limited progress in terms of an effective treatment for spinal cord injury (SCI)
emphasizes the urgent need for novel therapies. As a vital central nervous system …

Migraine is the second most common form of headache disorder and the second leading
cause of disability worldwide. Cognitive symptoms ranked second resulting in migraine …

High‐fat diet (HFD) has been recognized as a primary factor in the risk of chronic disease.
Obesity, diabetes, gastrointestinal diseases, neurodegenerative diseases, and …